These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16498501)

  • 41. Amyloid-beta antibody to restore cholinergic function?
    Burton A
    Lancet Neurol; 2006 Apr; 5(4):296-7. PubMed ID: 16578915
    [No Abstract]   [Full Text] [Related]  

  • 42. Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines.
    Mandler M; Santic R; Gruber P; Cinar Y; Pichler D; Funke SA; Willbold D; Schneeberger A; Schmidt W; Mattner F
    PLoS One; 2015; 10(1):e0115237. PubMed ID: 25611858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The SAMP8 mouse: a model of Alzheimer disease?
    Morley JE
    Biogerontology; 2002; 3(1-2):57-60. PubMed ID: 12014843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restoration of spatial memory dysfunction of human APP transgenic mice by transplantation of neuronal precursors derived from human iPS cells.
    Fujiwara N; Shimizu J; Takai K; Arimitsu N; Saito A; Kono T; Umehara T; Ueda Y; Wakisaka S; Suzuki T; Suzuki N
    Neurosci Lett; 2013 Dec; 557 Pt B():129-34. PubMed ID: 24466594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amyloid beta-peptide 25-35 reduces [3H]acetylcholine release in retinal neurons. Involvement of metabolic dysfunction.
    Melo JB; Agostinho P; Oliveira CR
    Amyloid; 2002 Dec; 9(4):221-8. PubMed ID: 12557749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of amyloid-beta 1-40 and 1-42 peptides in Capsicum annum var. angulosum for oral immunization.
    Szabó B; Hori K; Nakajima A; Sasagawa N; Watanabe Y; Ishiura S
    Assay Drug Dev Technol; 2004 Aug; 2(4):383-8. PubMed ID: 15357919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyloid beta vaccination: reduced plaques and improved cognition.
    Younkin SG
    Nat Med; 2001 Jan; 7(1):18-9. PubMed ID: 11135604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link?
    Auld DS; Kar S; Quirion R
    Trends Neurosci; 1998 Jan; 21(1):43-9. PubMed ID: 9464686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amino-Terminal β-Amyloid Antibody Blocks β-Amyloid-Mediated Inhibition of the High-Affinity Choline Transporter CHT.
    Cuddy LK; Seah C; Pasternak SH; Rylett RJ
    Front Mol Neurosci; 2017; 10():361. PubMed ID: 29163036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of human amyloid restricted to liver results in an Alzheimer disease-like neurodegenerative phenotype.
    Lam V; Takechi R; Hackett MJ; Francis R; Bynevelt M; Celliers LM; Nesbit M; Mamsa S; Arfuso F; Das S; Koentgen F; Hagan M; Codd L; Richardson K; O'Mara B; Scharli RK; Morandeau L; Gauntlett J; Leatherday C; Boucek J; Mamo JCL
    PLoS Biol; 2021 Sep; 19(9):e3001358. PubMed ID: 34520451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curing amyloidosis: will it work in humans?
    Duff K
    Trends Neurosci; 1999 Nov; 22(11):485-6. PubMed ID: 10529812
    [No Abstract]   [Full Text] [Related]  

  • 52. [Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23].
    Irie K; Murakami K; Masuda Y; Murata N; Noda Y; Hatsuta H; Murayama S; Shimizu T; Horikoshi Y; Kinoshita N; Shirasawa T
    Rinsho Shinkeigaku; 2011 Nov; 51(11):890-1. PubMed ID: 22277406
    [No Abstract]   [Full Text] [Related]  

  • 53. The mice that missed.
    Rennie J
    Sci Am; 1992 Jun; 266(6):20-6. PubMed ID: 1585149
    [No Abstract]   [Full Text] [Related]  

  • 54. Conclusions and comments for the XII ISCM.
    Karczmar AG
    J Mol Neurosci; 2006; 30(1-2):237-42. PubMed ID: 17192684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices.
    Kar S; Issa AM; Seto D; Auld DS; Collier B; Quirion R
    J Neurochem; 1998 May; 70(5):2179-87. PubMed ID: 9572306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early hippocampal hyperexcitability and synaptic reorganization in mouse models of amyloidosis.
    Ray A; Loghinov I; Ravindranath V; Barth AL
    iScience; 2024 Sep; 27(9):110629. PubMed ID: 39262788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular docking analysis of acetylcholinesterase inhibitors for Alzheimer's disease management.
    Hakeem IJ
    Bioinformation; 2023; 19(5):565-570. PubMed ID: 37886145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin D alleviates cognitive dysfunction and brain damage induced by copper sulfate intake in experimental rats: focus on its combination with donepezil.
    Elseweidy MM; Mahrous M; Ali SI; Shaheen MA; Younis NN
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1931-1942. PubMed ID: 36864348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transgenic Mouse Models of Alzheimer's Disease: An Integrative Analysis.
    Sanchez-Varo R; Mejias-Ortega M; Fernandez-Valenzuela JJ; Nuñez-Diaz C; Caceres-Palomo L; Vegas-Gomez L; Sanchez-Mejias E; Trujillo-Estrada L; Garcia-Leon JA; Moreno-Gonzalez I; Vizuete M; Vitorica J; Baglietto-Vargas D; Gutierrez A
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinary Incontinence and Alzheimer's Disease: Insights From Patients and Preclinical Models.
    Bartolone SN; Sharma P; Chancellor MB; Lamb LE
    Front Aging Neurosci; 2021; 13():777819. PubMed ID: 34975457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.